Drug Combination Details
General Information of the Combination (ID: C23576) | |||||
---|---|---|---|---|---|
Name | Resveratrol NP Info | + | Melphalan Drug Info | ||
Structure |
![]() |
+ |
![]() |
||
Disease |
Breast cancer
[ICD-11: 2C60]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Augmenting Drug Sensitivity | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Up-regulation | Cleavage | CASP7 | Molecule Info |
Pathway MAP
|
|
Up-regulation | Cleavage | CASP9 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | CCNA1 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Phosphorylation | CDK2 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Phosphorylation | RAD53 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Expression | TP53 | Molecule Info |
Pathway MAP
|
||
In-vitro Model | MCF-7 | CVCL_0031 | Invasive breast carcinoma | Homo sapiens | ||
MDA-MB-231 | CVCL_0062 | Breast adenocarcinoma | Homo sapiens | |||
Experimental
Result(s) |
Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest. |
References | ||||
---|---|---|---|---|
Reference 1 | Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest. J Cell Biochem. 2012 Aug;113(8):2586-96. |





